DRUG DELIVERY FORMULATIONS

The disclosure provides drug delivery formulations that comprise a porous silicon material and a meltable compound, such as a progestin drug, or a meltable composition. The formulations provide for the controlled release of the progestin drug, or other therapeutic agent, over long time periods. In s...

Full description

Saved in:
Bibliographic Details
Main Authors HOLLETT, Geoffrey Ian, INGALLINERA, Thomas, SAILOR, Michael J
Format Patent
LanguageEnglish
French
German
Published 29.12.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The disclosure provides drug delivery formulations that comprise a porous silicon material and a meltable compound, such as a progestin drug, or a meltable composition. The formulations provide for the controlled release of the progestin drug, or other therapeutic agent, over long time periods. In some embodiments, the meltable composition further comprises a melting point suppression agent, where the melting point suppression agent enables the loading of thermally unstable therapeutic agents into the porous silicon material by melt casting that would not otherwise be possible absent the melting point suppression agent. The disclosure additionally provides methods of making and using the drug delivery formulations.
AbstractList The disclosure provides drug delivery formulations that comprise a porous silicon material and a meltable compound, such as a progestin drug, or a meltable composition. The formulations provide for the controlled release of the progestin drug, or other therapeutic agent, over long time periods. In some embodiments, the meltable composition further comprises a melting point suppression agent, where the melting point suppression agent enables the loading of thermally unstable therapeutic agents into the porous silicon material by melt casting that would not otherwise be possible absent the melting point suppression agent. The disclosure additionally provides methods of making and using the drug delivery formulations.
Author HOLLETT, Geoffrey Ian
SAILOR, Michael J
INGALLINERA, Thomas
Author_xml – fullname: HOLLETT, Geoffrey Ian
– fullname: INGALLINERA, Thomas
– fullname: SAILOR, Michael J
BookMark eNrjYmDJy89L5WSQcgkKdVdwcfXxDHMNilRw8w_yDfVxDPH09wvmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgHG5ubG5sYGjibGRCgBANj-IeI
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate FORMULATIONS D'ADMINISTRATION DE MÉDICAMENT
WIRKSTOFFFREISETZUNGSFORMULIERUNGEN
ExternalDocumentID EP3773730A4
GroupedDBID EVB
ID FETCH-epo_espacenet_EP3773730A43
IEDL.DBID EVB
IngestDate Fri Nov 08 04:49:30 EST 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP3773730A43
Notes Application Number: EP20190776288
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211229&DB=EPODOC&CC=EP&NR=3773730A4
ParticipantIDs epo_espacenet_EP3773730A4
PublicationCentury 2000
PublicationDate 20211229
PublicationDateYYYYMMDD 2021-12-29
PublicationDate_xml – month: 12
  year: 2021
  text: 20211229
  day: 29
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies The Regents of The University of California
RelatedCompanies_xml – name: The Regents of The University of California
Score 3.3709745
Snippet The disclosure provides drug delivery formulations that comprise a porous silicon material and a meltable compound, such as a progestin drug, or a meltable...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title DRUG DELIVERY FORMULATIONS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211229&DB=EPODOC&locale=&CC=EP&NR=3773730A4
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTdKSU60TLYErRK31DVJNE7RtUi2MNM1TktJS000BmYvc9BuZF8_M49QE68I0wgmhkzYXhjwOaHl4MMRgTkqGZjfS8DldQFiEMsFvLayWD8pEyiUb-8WYuuiBu0dA3szRsAOtIuTrWuAv4u_s5qzM5Cl5hdka2xubgxMzI4mzAyswFa0OSgzuIY5gTalFCDXKG6CDGwBQMPySoQYmFLzhBk4nWEXrwkzcPhC57uBTGjWKxZhkHIJCnVXcHH18QxzDYpUAHbefEN9IJuARRkU3FxDnD10gZbEwz0U7xoAd46xGAMLsJ-fKsGgYGRgbmmWamxkmWaSZAJqOSQZGSSlmSWZW5obGSUnJ0sySOI0RgqPnDQDFyhkQGswjCxlGFhKikpTZYE1aUmSHDgMAOkOdGw
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH9BNOJNUSP4tYPhtkjasdIDMbIWh26wkI3gaWFlS7ggkRn_fV_nQC96e2mTfqW_vvdr33sFuGNkoeZcce0lzk1rThdmV3Vtk2aLLJ1ThBfT0cj-yHYj63nWmVVguY2FKfKEfhbJERFRCvGeF-f1-ucSSxS-lZv7ZIlFbw-DsCdaJTtGNkOQQIt-TwZjMXZajoNSazTpUcYobuZHaw_20cJmGgxy2tdBKevfGmVwDAcBNrbKT6CSrupQc7Yfr9Xh0C_fu1Esobc5haaYRE-GkN5wKievBpI3P_K-g4DPwBjI0HFN7CTeTSiWwW449ByqyPPTCzBIm3E7pYRnVmJpyyEh7SSzE8YZIUqpBjT-bKb5T90t1NzQ92JvOHq5hCO9Stofg_ArqObvH-k1atU8uSnW4wuJBndf
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=DRUG+DELIVERY+FORMULATIONS&rft.inventor=HOLLETT%2C+Geoffrey+Ian&rft.inventor=INGALLINERA%2C+Thomas&rft.inventor=SAILOR%2C+Michael+J&rft.date=2021-12-29&rft.externalDBID=A4&rft.externalDocID=EP3773730A4